Skip navigation
中文
English
DSpace
CRIS
首頁
單位
研究人員
研究成果檢索
分類瀏覽
單位
研究人員
研究成果檢索
學術出版
幫助
登入
中文
English
NTU Scholars
國立臺灣大學
/
醫學院
/
病理學科所
YIH-LEONG CHANG
研究人員網路
瀏覽統計
Email 通知
RSS Feed
簡歷
研究成果
325
計畫
4
研究成果
(全部)
全部
期刊文章
回顧型論文
會議論文
其他
顯示/隱藏過濾條件
依作者
16
yih-leong chang
11
lee y.-c.
5
chong-jen yu
4
chih-hsin yang
3
pan-chyr yang
3
tzu-hsiu tsai
3
yih-leong chang ;wu c.-t. ;shih j.-y. ;lee y.-c.
2
bin-chi liao
2
chao-chi ho
2
chia-chi lin
.
下一頁 >
主題
15
[sdgs]sdg3
1
adult; aged; article; cancer invasion; cancer prognosis; cancer staging; cancer survival; female; human; lung non small cell cancer; lymph node metastasis; major clinical study; male; mediastinum lymph node; pleura disease; pleural retraction; visceral pleural surface invasion; adult; aged; aged, 80 and over; carcinoma, non-small-cell lung; female; humans; kaplan-meier estimate; lung neoplasms; lymphatic metastasis; male; middle aged; multivariate analysis; neoplasm grading; neoplasm invasiveness; neoplasm staging; pleura; prognosis; retrospective studies
1
anaplastic lymphoma kinase; crizotinib; programmed death 1 ligand 1; anaplastic lymphoma kinase; crizotinib; programmed death 1 ligand 1; protein kinase inhibitor; adult; aged; anaplastic large cell lymphoma; article; bioinformatics; cancer immunotherapy; cancer staging; cell infiltration; clinical outcome; cohort analysis; computer assisted tomography; female; gene mutation; high throughput sequencing; human; human tissue; immunofluorescence test; immunohistochemistry; lung adenocarcinoma; major clinical study; male; outcome assessment; overall survival; personalized medicine; prevalence; priority journal; protein expression; regulatory t lymphocyte; reverse transcription polymerase chain reaction; rna sequence; sanger sequencing; tumor microenvironment; very elderly; genetics; lung adenocarcinoma; lung tumor; mutation; adenocarcinoma of lung; anaplastic lymphoma kinase; b7-h1 antigen; crizotinib; humans; lung neoplasms; mutation; protein kinase inhibitors; tumor microenvironment
1
antiinfective agent; ki 67 antigen; oncoprotein; protein p53; adult; aged; body regions; cancer chemotherapy; cancer staging; clinical article; clinical feature; conference paper; controlled study; data analysis; differential diagnosis; disease association; female; human; human tissue; lung non small cell cancer; lymph node metastasis; male; mediastinum metastasis; necrosis; pleura metastasis; priority journal; protein expression; sex difference; smoking habit; spindle cell carcinoma; survival rate
1
antineoplastic agent; epidermal growth factor receptor; gefitinib; protein tyrosine kinase inhibitor; adrenal metastasis; adult; aged; article; bone metastasis; brain metastasis; cancer radiotherapy; controlled study; exon; female; gene mutation; gene sequence; human; human tissue; lung non small cell cancer; lung surgery; lymph node metastasis; major clinical study; male; metastasis; priority journal; skin metastasis; soft tissue metastasis; adult; aged; aged, 80 and over; carcinoma, non-small-cell lung; exons; female; humans; lung neoplasms; male; middle aged; mutation; neoplasm metastasis; protein kinase inhibitors; protein-tyrosine kinases; receptor, epidermal growth factor
1
carcinoembryonic antigen; epidermal growth factor receptor; protein p53; protein tyrosine kinase inhibitor; adult; aged; article; cancer recurrence; cancer staging; cancer surgery; cancer survival; cell differentiation; correlation analysis; disease free survival; female; gene mutation; human; human tissue; lung adenocarcinoma; lung alveolus cell carcinoma; lymph node metastasis; major clinical study; male; missense mutation; mutational analysis; overall survival; preoperative period; priority journal; risk factor; survival rate; tumor volume; epidermal growth factor receptor; lung adenocarcinoma; p53; adenocarcinoma; adult; aged; aged, 80 and over; antineoplastic agents; dna mutational analysis; dna, neoplasm; enzyme inhibitors; female; genes, erbb-1; genes, p53; genetic markers; humans; lung neoplasms; male; middle aged; mutation; neoplasm recurrence, local; neoplasm staging; pneumonectomy; prognosis; protein-tyrosine kinases; survival analysis; tumor burden; tumor markers, biological
1
cd8 antigen; immunoglobulin g antibody; latent membrane protein 1; oncoprotein; protein bcl 2; protein p53; virus capsid antigen; adult; aged; antibody titer; article; cancer chemotherapy; cancer growth; cancer registry; cancer size; cancer staging; cell differentiation; chinese; clinical article; clinical feature; controlled study; disease association; drug response; epstein barr virus; female; histopathology; human; human tissue; in situ hybridization; lung alveolus epithelium; lung carcinoma; lymphoepithelioma; male; oncogene c erb; protein expression; serodiagnosis; smoking; syncytium; t lymphocyte subpopulation; tumor suppressor gene; virus carcinogenesis; virus infection; adult; aged; aged, 80 and over; antigens, viral; capsid proteins; carcinoma; cd8-positive t-lymphocytes; cell count; female; herpesviridae infections; herpesvirus 4, human; humans; immunohistochemistry; in situ hybridization; lung neoplasms; male; middle aged; neoplasm staging; proto-oncogene proteins c-bcl-2; rna, viral; tumor suppressor protein p53
1
cell lung-cancer; epidermal-growth-factor; factor-receptor mutations; tyrosine kinase; immunohistochemical detection; gefitinib; adenocarcinoma; tumors; chemotherapy; inhibitor
1
cisplatin; docetaxel; epidermal growth factor receptor; gemcitabine; protein p53; adult; aged; article; cancer chemotherapy; carcinogenesis; clinical article; controlled study; exon; female; gender; gene deletion; gene mutation; human; human tissue; lung carcinoma; lymphoepithelioma; male; priority journal; pulmonary lymphoepithelioma like carcinoma; tumor volume; adult; aged; aged, 80 and over; carcinoma, non-small-cell lung; female; genes, p53; humans; lung neoplasms; male; middle aged; mutation; receptor, epidermal growth factor
1
epidermal growth factor receptor; erlotinib; gefitinib; adult; advanced cancer; aged; antibody combining site; article; clinical practice; controlled study; cytopathology; exocrine cell; exon; female; gene deletion; gene mutation; human; human cell; immunocytochemistry; immunohistochemistry; immunoreactivity; lung adenocarcinoma; lung non small cell cancer; major clinical study; male; overall survival; pleura effusion; predictive value; priority journal; progression free survival; retrospective study; sensitivity and specificity; sequence analysis; smoking; treatment response; wild type
.
下一頁 >
依日期
9
2010 - 2020
7
2001 - 2009
依類型
13
journal article
1
conference paper
1
letter
1
journal article
全文
16
no fulltext
關閉過濾條件
再查詢
作者:
chen-tu wu
作者:
jin-yuan shih
第 1 到 16 筆結果,共 16 筆。
公開日期
標題
作者
來源出版物
scopus
WOS
全文
1
2020
Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors
CHING-YAO YANG
; WEI-YU LIAO
; CHAO-CHI HO
; KUAN-YU CHEN
; TZU-HSIU TSAI
; CHIA-LIN HSU
; KANG-YI SU
; YIH-LEONG CHANG
; CHEN-TU WU
; Chia-Chi Hsu; BIN-CHI LIAO
; Wei-Hsun Hsu; JIH-HSIANG LEE
; CHIA-CHI LIN
; JIN-YUAN SHIH
; CHIH-HSIN YANG
; CHONG-JEN YU
European Journal of Cancer
55
49
2
2020
Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib
CHING-YAO YANG
; WEI-YU LIAO
; CHAO-CHI HO
; KUAN-YU CHEN
; TZU-HSIU TSAI
; CHIA-LIN HSU
; Liu, Yi-Nan; KANG-YI SU
; YIH-LEONG CHANG
; CHEN-TU WU
; BIN-CHI LIAO
; Hsu, Chia-Chi; Hsu, Wei-Hsun; JIH-HSIANG LEE
; CHIA-CHI LIN
; JIN-YUAN SHIH
; CHIH-HSIN YANG
; CHONG-JEN YU
Oncologist
15
15
3
2014
Clinicopathologic characteristics and prognostic significance of EGFR and p53 mutations in surgically resected lung adenocarcinomas ≤2 cm in maximal dimension
MONG-WEI LIN
; CHEN-TU WU
; JIN-YUAN SHIH
; YIH-LEONG CHANG
; PAN-CHYR YANG
Journal of Surgical Oncology
32
29
4
2012
The significance of visceral pleural surface invasion in 321 cases of non-small cell lung cancers with pleural retraction
YIH-LEONG CHANG
; MONG-WEI LIN
; JIN-YUAN SHIH
; CHEN-TU WU
; Lee Y.-C.
Annals of Surgical Oncology
26
20
5
2012
Effusion immunocytochemistry as an alternative approach for the selection of first-line targeted therapy in advanced lung adenocarcinoma
TZU-HSIU TSAI
; SHANG-GIN WU
; YIH-LEONG CHANG
; CHEN-TU WU
; Tsai M.-F.; Wei P.-F.; CHIH-HSIN YANG
; CHONG-JEN YU
; PAN-CHYR YANG
; JIN-YUAN SHIH
Journal of Thoracic Oncology
22
26
6
2011
Including total EGFR staining in scoring improves EGFR mutations detection by mutation-specific antibodies and EGFR TKIs response prediction
SHANG-GIN WU
; YIH-LEONG CHANG
; JOU-WEI LIN
; CHEN-TU WU
; Chen, Hsuan-Yu; Tsai, Meng-Feng; Lee, Yung-Chie; CHONG-JEN YU
; JIN-YUAN SHIH
PloS one
49
43
7
2011
EGFR and p53 status of pulmonary pleomorphic carcinoma: Implications for EGFR tyrosine kinase inhibitors therapy of an aggressive lung malignancy
YIH-LEONG CHANG
; CHEN-TU WU
; JIN-YUAN SHIH
; Lee Y.-C.
Annals of Surgical Oncology
48
43
8
2011
Unique p53 and epidermal growth factor receptor gene mutation status in 46 pulmonary lymphoepithelioma-like carcinomas
YIH-LEONG CHANG
; CHEN-TU WU
; JIN-YUAN SHIH
; Lee Y.-C.
Cancer Science
63
58
9
2011
Comparison of p53 and epidermal growth factor receptor gene status between primary tumors and lymph node metastases in non-small cell lung cancers
YIH-LEONG CHANG
; CHEN-TU WU
; JIN-YUAN SHIH
; Lee Y.-C.
Annals of Surgical Oncology
44
38
10
2009
Comparison of epidermal growth factor receptor mutations between primary and corresponding metastatic tumors in tyrosine kinase inhibitor-naive non-small-cell lung cancer
Gow C.-H.; YIH-LEONG CHANG
; Hsu Y.-C.; Tsai M.-F.; CHEN-TU WU
; CHONG-JEN YU
; CHIH-HSIN YANG
; Lee Y.-C.; PAN-CHYR YANG
; JIN-YUAN SHIH
Annals of Oncology
195
172
11
2006
Estrogen receptor β - Which one and where should we draw the line - Reply [2]
CHEN-TU WU
; YIH-LEONG CHANG
; JIN-YUAN SHIH
; Lee Y.-C.
Human Pathology
0
0
12
2005
The significance of estrogen receptor β in 301 surgically treated non-small cell lung cancers
CHEN-TU WU
; YIH-LEONG CHANG
; JIN-YUAN SHIH
; Lee Y.-C.
Journal of Thoracic and Cardiovascular Surgery
162
143
13
2004
Frequent allelic deletion at the FHIT locus associated with p53 overexpression in squamous cell carcinoma subtype of Taiwanese non-small-cell lung cancers
Lee Y.-C.; CHEN-TU WU
; JIN-YUAN SHIH
; Jou Y.-S.; YIH-LEONG CHANG
British Journal of Cancer
14
14
14
2003
Roles of Fhit and p53 in Taiwanese surgically treated non-small-cell lung cancers
YIH-LEONG CHANG
; CHEN-TU WU
; JIN-YUAN SHIH
; Lee Y.-C.
British Journal of Cancer
11
10
15
2002
New aspects in clinicopathologic and oncogene studies of 23 pulmonary lymphoepithelioma-like carcinomas
YIH-LEONG CHANG
; CHEN-TU WU
; JIN-YUAN SHIH
; Lee Y.-C.
American Journal of Surgical Pathology
104
84
16
2001
Pulmonary pleomorphic (spindle) cell carcinoma: Peculiar clinicopathologic manifestations different from ordinary non-small cell carcinoma
YIH-LEONG CHANG
; Lee Y.-C.; JIN-YUAN SHIH
; CHEN-TU WU
Lung Cancer
174
135
申請連結研究人員資料
以 ORCID 登入申請連結此個人資料
ORCID Login
Contact via feedback form
若您要聯絡網站管理員,請點選以下按鈕